Clinical Trial Update: Hypofractionated Stereotactic Body Radiation Therapy as a Boost to the Prostate [NA]

View source ↗

Summary

This document provides a clinical trial update on using hypofractionated stereotactic body radiation therapy as a boost for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Boston Medical Center | Conditions: Prostate Cancer | NA | Status: ACTIVE_NOT_RECRUITING